Please wait
0001590750Viridian Therapeutics, Inc.\DEEX-FILING FEESfalsefalsefalsefalsefalsefalse0.00015310.00015310.00015310.00015310.00015310.0001531 0001590750 2025-03-03 2025-03-03 0001590750 5 2025-03-03 2025-03-03 0001590750 6 2025-03-03 2025-03-03 0001590750 1 2025-03-03 2025-03-03 0001590750 2 2025-03-03 2025-03-03 0001590750 3 2025-03-03 2025-03-03 0001590750 4 2025-03-03 2025-03-03 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107.1
Form
S-8
(Form Type)
VIRIDIAN THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
               
Security
Type
  
Security
Class
Title(1)
   Fee
Calculation
Rule
  
Amount
Registered
(1)
  
Proposed
Maximum
Offering
Price Per
Share
  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
  
Amount of
Registration
Fee
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on September 3, 2024    Other(2)    158,000    $14.47 (2)    $2,286,260(2)    $
153.10
 per $1,000,000
   $350.03
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on October 1, 2024    Other(2)    201,000    $23.61 (2)    $4,745,610(2)    $
153.10
per $1,000,000
   $726.56
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on November 1, 2024    Other(2)    123,600    $22.28 (2)    $2,753,808(2)    $
153.10
per $1,000,000
   $421.61
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on December 2, 2024    Other(2)    391,500    $21.00 (2)    $8,221,500(2)    $
153.10
per $1,000,000
   $1,258.72
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on January 2, 2025    Other(2)    98,500    $19.76 (2)    $1,946,360(2)    $
153.10
per $1,000,000
   $297.99
               
Equity    Common Stock, $0.01 par value per share, to be issued pursuant to a Stock Option Inducement Award granted on February 3, 2025    Other(2)    527,750    $19.30 (2)    $10,185,575(2)    $
153.10
per $1,000,000
   $1,559.42
           
Total Offering Amounts          $30,139,113       $4,614.33
           
Total Fee Offsets                $0.00
           
Net Fee Due                        $4,614.33
 
(1)
Represents 1,500,350 shares of common stock of the Company issuable pursuant to the Stock Option Inducement Awards granted on September 3, 2024, October 1, 2024, November 1, 2024, December 2, 2024, January 2, 2025, and February 3, 2025. Pursuant to Rule 416 of the Securities Act of 1933 (the “Securities Act”), this Registration Statement on Form
S-8
(this “Registration Statement”), also includes additional shares of common stock of the Registrant in respect of the securities identified in the above table that may become issuable through the Stock Option Inducement Awards as a result of any stock dividend, stock split, recapitalization or other similar transactions.
(2)
Estimated solely for calculating the registration fee, pursuant to paragraph (h)(1) of Rule 457 under the Securities Act. The proposed maximum offering price per share and maximum aggregate offering price are calculated using the exercise price for the Registrant’s Common Stock subject to such inducement grants.